Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 6/2005

01-06-2005 | Article

A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam Study cohort

Authors: C. Heidemann, K. Hoffmann, J. Spranger, K. Klipstein-Grobusch, M. Möhlig, A. F. H. Pfeiffer, H. Boeing

Published in: Diabetologia | Issue 6/2005

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to identify a dietary pattern associated with diabetes-related biomarkers and to investigate whether this pattern is associated with the incidence of type 2 diabetes.

Methods

A nested case–control study of 192 cases of incident type 2 diabetes and 382 control subjects matched for sex and age was conducted. All subjects were participants in the population-based European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam Study. Dietary pattern score was derived using intake data on 48 food groups as exposure variables and the biomarkers HbA1c, HDL cholesterol, C-reactive protein and adiponectin as response variables in reduced rank regression. The association of the score with diabetes risk was estimated by conditional logistic regression analysis.

Results

A high score for the identified dietary pattern was characterised by a high intake of fresh fruit and a low intake of high-caloric soft drinks, beer, red meat, poultry, processed meat, legumes and bread (excluding wholegrain bread). Subjects with high scores had high plasma concentrations of HDL cholesterol and adiponectin and low plasma concentrations of HbA1c and C-reactive protein. After multivariate adjustment, the odds ratios for type 2 diabetes across increasing quintiles of the dietary pattern score were 1.0, 0.59, 0.51, 0.26 and 0.27, respectively (p=0.0006 for trend).

Conclusions/interpretation

A high score for the identified dietary pattern is associated with a more favourable biomarker profile and a substantially reduced incidence of type 2 diabetes.
Literature
1.
King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431PubMed
2.
Centers for Disease Control and Prevention (2004) The burden of heart disease, stroke, cancer, and diabetes, United States. In: The burden of chronic diseases and their risk factors. National and state perspectives 2004. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, p 29
3.
Hu FB, van Dam RM, Liu S (2001) Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44:805–817CrossRefPubMed
4.
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277:472–477CrossRefPubMed
5.
Lopez-Ridaura R, Willett WC, Rimm EB et al (2004) Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 27:134–140PubMed
6.
Hu FB (2002) Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 13:3–9CrossRefPubMed
7.
Williams DE, Prevost AT, Whichelow MJ, Cox BD, Day NE, Wareham NJ (2000) A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome. Br J Nutr 83:257–266PubMed
8.
Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B (1998) Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr 128:541–547PubMed
9.
van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB (2002) Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 136:201–209PubMed
10.
Newby PK, Tucker KL (2004) Empirically derived eating patterns using factor or cluster analysis: a review. Nutr Rev 62:177–203CrossRefPubMed
11.
Hoffmann K, Schulze MB, Schienkiewitz A, Nothlings U, Boeing H (2004) Application of a new statistical method to derive dietary patterns in nutritional epidemiology. Am J Epidemiol 159:935–944CrossRefPubMed
12.
Hoffmann K, Zyriax BC, Boeing H, Windler E (2004) A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease. Am J Clin Nutr 80:633–640PubMed
13.
Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J (1997) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S59–S70CrossRefPubMed
14.
Kroke A, Klipstein-Grobusch K, Voss S et al (1999) Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am J Clin Nutr 70:439–447PubMed
15.
Schulze MB, Hoffmann K, Kroke A, Boeing H (2003) Risk of hypertension among women in the EPIC—Potsdam study: comparison of relative risk estimates for exploratory and hypothesis-oriented dietary patterns. Am J Epidemiol 158:365–373CrossRefPubMed
16.
Klipstein-Grobusch K, Georg T, Boeing H (1997) Interviewer variability in anthropometric measurements and estimates of body composition. Int J Epidemiol 26(Suppl 1):S174–S180CrossRefPubMed
17.
Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976) Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 295:417–420PubMed
18.
Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE (2001) The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 47:1985–1992PubMed
19.
Pratley RE, Weyer C (2002) Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion. Curr Diab Rep 2:242–248PubMed
20.
Edelstein SL, Knowler WC, Bain RP et al (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701–710PubMed
21.
de Vegt F, Dekker JM, Jager A et al (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285:2109–2113CrossRefPubMed
23.
Ginsberg HN (1996) Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 45(Suppl 3):S27–S30PubMed
24.
Spranger J, Kroke A, Mohlig M et al (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam study. Diabetes 52:812–817PubMed
25.
Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241–1248CrossRefPubMed
26.
Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693–700PubMed
27.
Freeman DJ, Norrie J, Caslake MJ et al (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary prevention study. Diabetes 51:1596–1600PubMed
28.
Barzilay JI, Abraham L, Heckbert SR et al (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health study. Diabetes 50:2384–2389PubMed
29.
Ouchi N, Kihara S, Arita Y et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296–1301PubMed
30.
Stefan N, Vozarova B, Funahashi T et al (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51:1884–1888PubMed
31.
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed
32.
Spranger J, Kroke A, Mohlig M et al (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226–228CrossRefPubMed
33.
Kroenke CH, Chu NF, Rifai N et al (2003) A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diabetes Care 26:1971–1978PubMed
34.
Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ (1999) Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319:1523–1528PubMed
35.
Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357:763–767CrossRefPubMed
36.
Sierksma A, Patel H, Ouchi N et al (2004) Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 27:184–189PubMed
37.
Harding AH, Sargeant LA, Welch A et al (2001) Fat consumption and HbA(1c) levels: the EPIC—Norfolk study. Diabetes Care 24:1911–1916PubMed
38.
Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC (1999) Trans fatty acids and coronary heart disease. N Engl J Med 340:1994–1998CrossRefPubMed
39.
Ajani UA, Ford ES, Mokdad AH (2004) Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J Nutr 134:1181–1185PubMed
40.
Brand-Miller J, Hayne S, Petocz P, Colagiuri S (2003) Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 26:2261–2267PubMed
41.
Hallez S, Derounane A (1982) Novelle methode de traitement de séries de données tronquées dans l’ étude de la pollutions atmospherique [article in French]. Sci Total Environ 22:115–123CrossRef
42.
van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB (2002) Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25:417–424PubMed
43.
Schulze MB, Manson JE, Willett WC, Hu FB (2003) Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women. Diabetologia 46:1465–1473CrossRefPubMed
44.
Wirfalt E, Hedblad B, Gullberg B et al (2001) Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the malmo diet and cancer cohort. Am J Epidemiol 154:1150–1159CrossRefPubMed
45.
Martin-Villa MC, Vidal-Valverde C, Rojas-Hidalgo E (1981) Soluble sugars in soft drinks. Am J Clin Nutr 34:2151–2153PubMed
46.
Janssens JP, Shapira N, Debeuf P et al (1999) Effects of soft drink and table beer consumption on insulin response in normal teenagers and carbohydrate drink in youngsters. Eur J Cancer Prev 8:289–295PubMed
47.
Selby JV, Newman B, King MC, Friedman GD (1987) Environmental and behavioral determinants of fasting plasma glucose in women. A matched co-twin analysis. Am J Epidemiol 125:979–988PubMed
48.
Jose Gerard M, Klatsky AL, Siegelaub AB, Friedman GD, Feldman R (1977) Serum glucose levels and alcohol-consumption habits in a large population. Diabetes 26:780–785PubMed
49.
Marlett JA, McBurney MI, Slavin JL (2002) Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 102:993–1000CrossRefPubMed
50.
Jenkins DJ, Kendall CW, Marchie A et al (2003) Type 2 diabetes and the vegetarian diet. Am J Clin Nutr 78:610S–616SPubMed
51.
Branca F, Hanley AB, Pool-Zobel B, Verhagen H (2001) Biomarkers in disease and health. Br J Nutr 86(Suppl 1):S55–S92PubMed
Metadata
Title
A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam Study cohort
Authors
C. Heidemann
K. Hoffmann
J. Spranger
K. Klipstein-Grobusch
M. Möhlig
A. F. H. Pfeiffer
H. Boeing
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1743-1

Other articles of this Issue 6/2005

Diabetologia 6/2005 Go to the issue

Article

Dysregulation of energy homeostasis in mice overexpressing insulin-like growth factor-binding protein 6 in the brain

Erratum

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)

Drug Watch

Pendra goes Dutch: lessons for the CE mark in Europe

Article

RETRACTED ARTICLE: Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats

Article

Adult BMI and fat distribution but not height amplify the effect of low birthweight on insulin resistance and increased blood pressure in 20-year-old South Africans

Short Communication

Birthweight and risk of type 1 diabetes in children and young adults: a population-based register study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits